# BMAC & Allograft vs BMP-2

> **NCT02924571** · NA · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 59 (actual)

## Conditions studied

- Spinal Fusion

## Interventions

- **DEVICE:** Bone Marrow Aspirate Concentrate (BMAC) + Allograft
- **DEVICE:** Recombinant Human Bone Morphogenetic Protein-2 (BMP)
- **PROCEDURE:** Autograft

## Key facts

- **NCT ID:** NCT02924571
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-24
- **Primary completion:** 2024-06-03
- **Final completion:** 2024-06-03
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02924571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02924571, "BMAC & Allograft vs BMP-2". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02924571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*